Treatment with nerinetide or AVLX-144 alone will inhibit pro-death pathways activated by coupling of the NMDARs and nNOS in stroke but would not affect PSD-95 processing by calpain, still leading to profound changes in PSD and synapses (Figure 3B). This evidence concerns the gene NOS1 and Stroke.